Evidence map›Paper›PMID 36003139›Full record

ArticleFrontiers in cellular neuroscience2022

R Scott Duncan, Sean M Riordan, Conner W Hall, Andrew J Payne, Kent D Chapman, Peter Koulen

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Oxidative Stress in Brain Function.Antioxidants (Basel, Switzerland) · 2025
    Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

R Scott DuncanDepartment of Ophthalmology, Vision Research Center, School of Medicine, University of Missouri-Kansas City, Kansas City, MO, United States.
Sean M RiordanDepartment of Ophthalmology, Vision Research Center, School of Medicine, University of Missouri-Kansas City, Kansas City, MO, United States.
Conner W HallDepartment of Ophthalmology, Vision Research Center, School of Medicine, University of Missouri-Kansas City, Kansas City, MO, United States.
Andrew J PayneDepartment of Ophthalmology, Vision Research Center, School of Medicine, University of Missouri-Kansas City, Kansas City, MO, United States.
Kent D ChapmanDepartment of Biological Sciences, Center for Plant Lipid Research, University of North Texas, Denton, TX, United States.
Peter KoulenDepartment of Ophthalmology, Vision Research Center, School of Medicine, University of Missouri-Kansas City, Kansas City, MO, United States.
City Vision University · USUniversity of Missouri–Kansas City · USUniversity of North Texas · US

Funding

Novel mechanism controlling calcium signaling to treat and prevent neurodegeneration in early stage glaucomaR01EY031248 · NEI · UNIVERSITY OF MISSOURI KANSAS CITY · PI KOULEN, PETER · 2020 to 2022
$1.7M
Novel pro-drug pharmacotherapy to prevent neuronal and cell degeneration in AMDR01EY030747 · NEI · UNIVERSITY OF MISSOURI KANSAS CITY · PI KOULEN, PETER · 2019 to 2021
$1.6M
Confocal Laser Scanning MicroscopeS10RR027093 · NCRR · UNIVERSITY OF MISSOURI KANSAS CITY · PI KOULEN, PETER · 2010 to 2010
$497k
NCRR NIH HHS S10 RR027093NEI NIH HHS R01 EY030747NEI NIH HHS R01 EY031248
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cannabinoidN-acylethanolamideneuronsneuroprotectionoxidative stresstranscription factor

Identifiers

PMID36003139
PMCPMC9393304
OpenAlexW4290547046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.